CHICAGO — Efforts are being made in the U.S. Congress to cap the price of insulin at $35 per month through the Affordable Insulin Now Act.
A press release from Sen. Dick Durbin’s office (IL-D) states an estimated 34 million Americans have been diagnosed with diabetes and approximately eight million Americans — 250,000 in Illinois — rely on insulin to manage their blood sugar levels.
Durbin discussed the Affordable Insulin Now Act, which would reduce the cost of a 30-day supply of insulin through federal regulation, at an event on Friday. The bill was first introduced in the House on February 25, 2022, and passed with a vote of 232 to 193. It was moved to the Senate on April 4 where Durbin is a co-sponsor.
If signed into law in its current form the $35 limit would impact all private health insurance and Medicare beneficiaries beginning in 2023.
As of January 2021, Illinois is one of only a few states that caps the cost of insulin at $100 per month. However the state law does not apply to every insurance plan and even in Illinois there are many who have difficulty affording a steady supply. In a previous WGN article, the governor’s office cited data indicating insulin brands that sold for $40 in 2001 had risen to $289 in 2020.